Department of Medicine

VUMC’s new automated biobanking system can store as many as 10 million biospecimens.
June 8, 2022

BioVU celebrates 15 years supporting personalized medicine

BioVU is celebrating its 15th year and has enabled hundreds of studies and publications exploring the genetic underpinnings of a host of conditions including cancer, heart disease and diabetes. 

By Lindsey Guerin
June 6, 2022

June Medicine Grand Rounds announced

By VUMC News and Communications
June 3, 2022

Food allergy linked to lower risk of SARS-CoV-2 infection

By Nancy Humphrey
June 2, 2022

Study explores positioning options to improve COVID mortality

Vanderbilt researchers found that prone positioning of patients with COVID-19-related hypoxemia not on mechanical ventilation offered no observed clinical benefit among these patients.

By Nancy Humphrey
June 2, 2022

Scale measures confidence with telehealth technology

Vanderbilt’s Digital Health Care Literacy Scale uses responses to three brief items to assess whether patients or caregivers are apt to have the confidence and basic know-how required to use digital health care services such as telehealth.

By Paul Govern
June 2, 2022

VUMC renewed as a Comprehensive Hypertension Center

The Vanderbilt Comprehensive Hypertension Center has been awarded renewal of the American Heart Association’s Comprehensive Hypertension Center Certification,

By Matt Batcheldor
May 26, 2022

Conquer Cancer awards given to five hematology-oncology fellows

Five Vanderbilt University Medical Center hematology and oncology fellows will receive awards from Conquer Cancer, the ASCO Foundation, during the 2022 American Society of Clinical Oncology Annual Meeting in Chicago, June 3-7.
By Tom Wilemon
May 25, 2022

Study seeks to improve gender equity for liver transplantation waiting list

Women who need a liver transplant are more likely to spend more time on a waiting list, become too sick for transplant or die compared to men. To improve equity, a recently published Vanderbilt-led study suggests a sex adjustment to criteria for MELD (model for end-stage liver disease), which determines allocation of transplanted livers.
By Matt Batcheldor
May 24, 2022

Diabetes, cardiovascular drug targets

Targeting receptors of the inflammatory lipid signaling molecule PGE2 may offer a new way to tackle both Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered.
By Leigh MacMillan
May 23, 2022

Vanderbilt Diabetes Day celebrates investigational achievements, looks toward future

Vanderbilt Diabetes Day, an annual event that showcases the work of outstanding scientists and researchers in the fields of diabetes, obesity and metabolism was held this month, and it marked the first time many investigators working under the auspices of the Vanderbilt Diabetes Research and Training Center (DRTC) had gathered in one space since the beginning of the COVID-19 pandemic.
By Jill Clendening
May 12, 2022

Study sheds light on the dark side of obesity

Vanderbilt research that promotes the anti-inflammatory pathway in macrophages could also reduce some of the bad side effects of obesity.
By Bill Snyder
May 12, 2022

Fissell receives Medal of Excellence from the American Association of Kidney Patients

Vanderbilt's William Fissell, MD, recently received the 2022 Medal of Excellence Award in the physician category from the American Association of Kidney Patients.
By Emily Stembridge
May 6, 2022

Janet Darnell received a lifesaving lung transplant. Five months later she received lifesaving surgery for colon cancer. She calls herself a “walking miracle.”

Without the lung transplant, the cancer may never have been detected.
By Matt Batcheldor
1 … 43 44 45 46 47 … 124